R.H. Bluestein & Co’s iShares Core MSCI EAFE ETF IEFA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$4.19M Buy
79,615
+19,092
+32% +$1.12M 0.26% 47
2022
Q2
$3.56M Sell
60,523
-4,845
-7% -$311K 0.22% 51
2022
Q1
$4.54M Buy
65,368
+73
+0.1% +$5.16K 0.19% 51
2021
Q4
$4.87M Sell
65,295
-2,909
-4% -$219K 0.17% 47
2021
Q3
$5.06M Buy
68,204
+4,634
+7% +$353K 0.2% 45
2021
Q2
$4.76M Buy
63,570
+13,825
+28% +$1.04M 0.18% 48
2021
Q1
$3.58M Buy
49,745
+8,029
+19% +$574K 0.15% 49
2020
Q4
$2.88M Buy
41,716
+6,724
+19% +$435K 0.13% 63
2020
Q3
$2.11M Buy
34,992
+2,700
+8% +$163K 0.11% 61
2020
Q2
$1.85M Buy
32,292
+11,997
+59% +$650K 0.1% 72
2020
Q1
$1.01M Sell
20,295
-3,171
-14% -$189K 0.09% 74
2019
Q4
$1.53M Buy
23,466
+8,940
+62% +$567K 0.08% 57
2019
Q3
$887K Buy
+14,526
New +$877K 0.05% 78

Other funds holding IEFA

R.H. Bluestein & Co's IEFA Position: Q3 2022 in Review

R.H. Bluestein & Co increased its iShares Core MSCI EAFE ETF (IEFA) stake by 32% in Q3 2022, buying an estimated $1.12M and bringing the position to 79,615 shares worth $4.19M. The position accounts for 0.26% of the portfolio, ranked #47.

R.H. Bluestein & Co first reported a position in IEFA in Q3 2019 and has held it in 13 quarters since. The position peaked at $5.06M in Q3 2021. 1,411 funds tracked by Wall St. Rank hold IEFA as of Q3 2022.

  • R.H. Bluestein & Co held 79,615 shares of iShares Core MSCI EAFE ETF worth $4.19M as of Q3 2022.
  • R.H. Bluestein & Co bought 19,092 iShares Core MSCI EAFE ETF shares in Q3 2022, an estimated $1.12M.
  • iShares Core MSCI EAFE ETF made up 0.26% of R.H. Bluestein & Co's portfolio in Q3 2022, its #47 holding.
  • R.H. Bluestein & Co first reported a position in iShares Core MSCI EAFE ETF in Q3 2019 and has held it in 13 quarters since.
  • R.H. Bluestein & Co's iShares Core MSCI EAFE ETF position peaked at $5.06M in Q3 2021.
  • 1,411 funds tracked by Wall St. Rank held iShares Core MSCI EAFE ETF as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.